跳至主要内容
临床试验/CTRI/2017/08/009221
CTRI/2017/08/009221招募中2 期

A randomised double blind study of prophylactic leviteracetam for the prevention of post stroke seizures - PROLEVIS

Pondicherry Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age above 18 years
  • Patients with acute ischemic stroke (arterial or venous) or parenchymal intracerebral hemorrhage with a cortical syndrome (clinically or imaging wise)
  • Presenting within one week of an arterial stroke and 2 weeks of confirming a venous thrombosis.

排除标准

  • 1. Previous history of epilepsy or treatment with an AED
  • 2. Life expectation less than 1 month due to stroke or other life-threatening comorbidity
  • 3. Subarachnoid or intraventricular hemorrhage
  • 4.Isolated posterior circulation stroke involving brainstem or cerebellum
  • 5. ICVT without cortical syndrome (clinical or radiological)
  • 6. ICH due to brain tumor, trauma, vascular malformation, brain surgery or infection
  • 7. Pre-existing dementia
  • 8.Known allergy to Levieracetam

研究者

相似试验